Pentax Medical Pushes People, Product And Process Amid New US FDA Guidance

With the US FDA urging providers to transition away from fixed duodenoscopes to newer designs that reduce or eliminate reprocessing of the device, Pentax Medical is seizing an opportunity to increase supply of its disposable cap scope. Medtech Insight talks to the company’s global clinical officer, Garrett Hudson, on the challenges of endoscopy hygiene and the company’s response to guidance.

Duodenoscopes are used in more than half a million endoscopic retrograde cholangiopancreatography (ERCP) procedures annually, but the prevention of cross-contamination in these medical devices continues to be a major challenge in clinical practice.

More from Regulation

More from Policy & Regulation